BioXcel Therapeutics Inc.

NASDAQ: BTAI · Real-Time Price · USD
1.70
0.14 (8.97%)
At close: Jun 16, 2025, 3:59 PM
1.69
-0.59%
Pre-market: Jun 17, 2025, 06:29 AM EDT

BioXcel Therapeutics Revenue

BioXcel Therapeutics reported an annual revenue of $2.27M, reflecting a 64.2% growth. For the quarter ending March 31, 2025, BioXcel Therapeutics generated $168K in revenue.
Revenue (ttm)
$2.27M
Revenue Growth
64.2%
Price / Sales Ratio
6.69
Revenue / Employee
$61.24K
Employees
37
Market Cap
10.3M

Revenue Chart

Revenue History

Fiscal Year End Revenue % Change
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.